The latest closing stock price for Enliven Therapeutics as of January 21, 2025 is 22.00.
An investor who bought $1,000 worth of Enliven Therapeutics stock at the IPO in 2023 would have $-74 today, roughly 0 times their original investment - a -3.75% compound annual growth rate over 2 years.
The all-time high Enliven Therapeutics stock closing price was 29.55 on November 06, 2024.
The Enliven Therapeutics 52-week high stock price is 30.03, which is 36.5% above the current share price.
The Enliven Therapeutics 52-week low stock price is 10.90, which is 50.5% below the current share price.
The average Enliven Therapeutics stock price for the last 52 weeks is 22.02.
An investor who bought $1,000 worth of Enliven Therapeutics stock at the IPO in 2023 would have $-74 today, roughly 0 times their original investment - a -3.75% compound annual growth rate over 2 years.
The all-time high Enliven Therapeutics stock closing price was 29.55 on November 06, 2024.
The Enliven Therapeutics 52-week high stock price is 30.03, which is 36.5% above the current share price.
The Enliven Therapeutics 52-week low stock price is 10.90, which is 50.5% below the current share price.
The average Enliven Therapeutics stock price for the last 52 weeks is 22.02.